Skip to main content
Equibles
GALT logo

GALT · Galectin Therapeutics Inc

Track GALT — free

Use GALT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GALT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.44 -0.09 (-2.55%) At close · Aug 14
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$346.92M
Shares
100.85M

Galectin Therapeutics Inc Earnings Call Transcripts

Every quarterly earnings call for Galectin Therapeutics Inc (GALT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Key facts CIK 1133416 CUSIP 363225202 13F (30d) 99 filings 97 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)